Marc Buyse is the founder of the International Drug Development Institute (IDDI), CluePoints and One2Treat. He is Associate Professor of Biostatistics at Hasselt University in Belgium. He holds degrees in engineering and statistics from Brussels University (ULB), management from the Cranfield School of Management (Cranfield, UK) and a doctorate in biostatistics from Harvard University (Boston, MA). He was President of the International Society for Clinical Biostatistics, President of the Quetelet Society, and Fellow of the Society for Clinical Trials. He worked at the EORTC (European Organization for Research and Treatment of Cancer) in Brussels and at the Dana Farber Cancer Institute in Boston. He has served on the editorial board of the journals Annals of Oncology, Biometrical Journal, Cancer Investigation, Clinical Trials, Journal of Clinical Oncology, Statistics in Biopharmaceutical Research, and Statistical Methods in Medical Research.
